Skip to main content

Table 4 Distribution of signs and symptoms among study participants

From: Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates

SYMPTOMS

TOTAL

Positive

OR (95% CI)

P-value

All Symptoms

8 (4.5)

1 (1.9)

0.50 (0.06–4.56)

0.539

Burning Sensation & Discharge only

3 (1.7)

2 (3.7)

7.00 (0.57–85.38)

0.127

Burning Sensation & Irritation only

11 (6.3)

7 (13.0)

6.13 (1.49–25.22)

0.012*

Burning Sensation only

4 (2.3)

1 (1.9)

1.17 (0.11–12.48)

0.899

Discharge only

59 (33.5)

18 (33.3)

1.54 (0.63–3.76)

0.347

Irritation & Discharge only

37 (21.0)

13 (24.1)

1.90 (0.72–5.02)

0.198

Irritation only

9 (5.1)

2 (3.7)

1.02 (0.18–5.59)

0.988

No symptom

45 (25.6)

10 (18.5)

1

 

Total

176 (100.0)

54 (100.0)

  
  1. X2 = 0.143
  2. Data is presented as frequency and percentage in parenthesis
  3. Positive represents pregnant women who were culture positive for VVC
  4. X2 is the p-value obtained with the chi-square test